• highly diverse exploration of original azaindole scaffold
• privileged structures for kinase and enzyme inhibitors
• scaffolds also present in GPCR inhibitors
• many example of better pharmacokinetics than indoles
• library based on 10 intermediates

• development of a new CNS predictive QSAR model
• model based on 975 drugs, from which around 90 % of them were correctly classified
• systematic CNS prediction on Chem-X-Infinity’s libraries
• 2,000+ compounds of high diversity available
• cherry-picking and custom format available

• small peptidomimetics for the exploration of peptide receptors and enzymes
• promiscuous linker with potent applications in several fields
• original molecules for fragment based drug discovery
• cherry-picking and custom format available

• highly original scaffolds
• high diversity of potential targets
• limited number of structures around each scaffold to quickly assess the relevance of each series
• library based on 60 intermediates

• small peptidomimetics for the exploration of peptide receptors and enzymes
• promiscuous linkers with applications for proteases
• original molecules for fragment based drug discovery
• cherry-picking and custom format available

• non peptide peptidomimetics for the exploration of peptide receptors and enzymes
• very diverse peptidomimetic and beta-turn structures
• large array of potential targets
• 2,000+ compounds of high diversity
• cherry-picking and custom format available

• diverse exploration of pyrazole-4-propionamides
• privileged structures for aminergic and peptidergic GPCRs and NSAIDs
• flexible structures to optimize position in the active sites
• library based on 10 intermediates